Control groupN = 90 | Intervention groupN = 89 | Difference betweengroups (95% CI) | |
---|---|---|---|
SCORE risk assessment: | |||
SCORE (%) | −1.6 (−2.2– -1.0)* | −1.8 (−2.4– -1.2)* | .2 (−.6–1.1) |
Risk reclassification: | |||
No change | 42 (46.7 %) | 44 (49.4 %) | 2.7 (−11.9–17.3) |
Improvement | 41 (45.6 %) | 37 (41.6 %) | 4.0 (−10.5–18.5) |
Deterioration | 7 (7.8 %) | 8 (9.0 %) | 1.2 (−6.9–9.3) |
Cardiovascular risk factors: | |||
Current smokers (Δ%) | −8.9 (−16.8– -3.9)*† | −11.2 (−19.7– -5.5)*† | 2.3 (−6.5–11.1) |
Phys. inactive participants (Δ%) | −4.5 (−11.2– -1.3)† | −11.8 (−20.6– -5.8)† | 7.3 (−.8–15.4) |
BMI (kg/m2) | -.1 (−.41–.28) | -.1 (−.38– .17) | .04 (−.4–.5) |
Waist circumference (cm) | −1.9 (−3.1– -.67)* | −3.7 (−4.8– -2.6)* | 1.8 (.2–3.4)* |
Syst. blood pressure (mmHg) | −5.6 (−8.5– -2.6)* | −6.8 (−10.3– -3.2)* | 1.2 (−3.4–5.8) |
Diast. blood pressure (mmHg) | −3.3 (−4.8– -1.8)* | −4.4 (−6.3– -2.4)* | 1.1 (−1.4–3.5) |
Blood test: | |||
Total cholesterol (mmol/l) | -.14 (−.31–.03) | -.32 (−.52– -.11)* | .17 (−.09–.44) |
HDL cholesterol (mmol/l) | .10 (.05–.14)* | .07 (.03–.11)* | .02 (−.04–.08) |
LDL cholesterol (mmol/l) | -.18 (−.34– -.02)* | -.34 (−.52– -.16)* | .16 (−.08–.39) |
Triglycerides (mmol/l) | -.07 (−.18–.04) | -.17 (−.32– -.03)* | .10 (−.08–.28) |
Tot. cholesterol/HDL ratio | -.34 (−.50– -.18)* | -.52 (−.73– -.32)* | .18 (−.08–.44) |
Glucose (mmol/l) | .28 (.15–.41)* | .17 (.06–.29)* | .11 (−.07–.28) |
Creatinine (mmol/l) | −6.0(−8.2– -3.7)* | −5.1 (−7.2– -2.9)* | -.9 (−4.0–2.2) |